Editors’ Picks, December 2025: Potent Molecular Glues, Personalized CAR T-cell Therapies, and More
The countdown to the new year is nearly upon us, but no need to count down to the last...
The countdown to the new year is nearly upon us, but no need to count down to the last...
Frank McCormick, PhD, FAACR, reflected on a career chasing the notorious RAS oncogene that earned him the inaugural Stephenson...
This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.
The latest edition of From the Bench features creative cancer research, including making tumors seem like pig organs, starving...
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk,...
New advances in our understanding of cancer cachexia may provide hope for patients with pancreatic cancer.
Researchers are looking into urine tests that could detect cancers earlier, including lung, ovarian, pancreatic, colorectal, and more.
Understanding pancreatic cancer’s strengths may provide clues to its weaknesses.
With a five-year survival rate of only 12.5%, any progress toward new therapeutic approaches for pancreatic cancer is welcomed...